BioSpace News Archive

Business

Moderna Bolsters mRNA Oncology Business with Autolus’ Proprietary Binders

Shares of Autolus were up more than 12% this morning after it forged an exclusive licensing agreement with Moderna to develop new messenger RNA therapeutics for cancer.

August 2, 2021
·
2 min read
·
Alex Keown
Deals

Aiming Antibodies at Coronaviruses, Adagio Targets $318 Million IPO

It is offering 17.7 million shares with an expected price between $16 and $18 per share. It will trade on the Nasdaq under the ADGI ticker symbol.

August 2, 2021
·
3 min read
·
Mark Terry
Drug Development

Study: Servier’s TIBSOVO Prolongs Survival in Untreated IDH1-Mutated AML

Late-phase trial data show Servier’s TIBSOVO, in conjunction with chemotherapy azacitidine, prolonged event-free survival in adult patients with previously untreated IDH1-mutated acute myeloid leukemia.

August 2, 2021
·
3 min read
·
Brandon May
Policy

Hansa Biopharma announces reimbursement in the Netherlands of Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

Hansa Biopharma, “Hansa”, the pioneer in enzyme technology for rare immunological conditions, announces that its first-in-class treatment Idefirix®▼ is, as of August 1, reimbursable and available for use in the Netherlands.

August 2, 2021
·
6 min read
Deals

TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas

TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced that it has finalized and closed on an agreement with Elanco Animal Health Incorporated to acquire the ownership and operations of its manufacturing site in Shawnee, Kansas.

August 2, 2021
·
3 min read
Drug Development

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

On July 30, Shenzhen Kangtai Biological Products Co., Ltd. was approved by the Philippine Food and Drug Administration to launch the phase III clinical trial of its independently developed Inactivated COVID-19 Vaccine in the local area.

August 2, 2021
·
1 min read
Traumatic Brain Injury (TBI) Monitoring Devices Market: The imaging devices segment accounted for the largest market share

Traumatic brain injury is a condition caused by a sudden damage to the brain as a result of trauma, accident, assaults, or sports injuries.

August 2, 2021
·
4 min read
Thrombolytic Therapy Market: Increase in the incidence of hypertension to drive the market

Blood clot is one of the serious complications in the human body. When blood clots, major arteries or veins are blocked which cease the normal blood flow.

August 2, 2021
·
5 min read
Synthetic siRNA Market Segmentation & Region-wise Outlook

Small interfering RNA or siRNA are a class of double-stranded RNA molecules, 20-25 base pairs in length.

August 2, 2021
·
4 min read
Optic Neuritis Treatment Market: Steroidal therapy is projected to hold major market share

Demyelinating inflammation of optic nerve is referred as optic neuritis. It is also commonly termed as optic papillitis and retro tubular neuritis.

August 2, 2021
·
5 min read